Hafiz Imran
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hafiz Imran has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
Bahaa Kaseer
Lifespan Cardiovascular Research Center Brown University Providence RI
2 shared publicationsGuangbin Shi
Lifespan Cardiovascular Research Center Brown University Providence RI
2 shared publications- Marwan Saad
Brown University Health Cardiovascular Institute, Providence, Rhode Island
2 shared publications Ning Jiang
Lifespan Cardiovascular Research Center Brown University Providence RI
2 shared publications- Samuel C. DudleyJr
Cardiovascular Division, Department of Medicine, The Lillehei Heart Institute, University of Minnesota at Twin Cities, Minneapolis, MN 55455, USA
2 shared publications Aakash Garg
Division of Cardiology, Ellis Hospital, Schenectady, New York
1 shared publication
Latest Publications
- Open Access
- 4 February 2025
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 4 (3) , 102513
Ipsilateral Safety Wire as Bailout for MANTA Failure in Patients Undergoing Transcatheter Aortic Valve Replacement
- 4 February 2025
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 4 (3) , 102513
Open AccessIpsilateral Safety Wire as Bailout for MANTA Failure in Patients Undergoing Transcatheter Aortic Valve Replacement
- Open Access
- 7 November 2023
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (21) , e030953
Transcatheter Versus Surgical Aortic Valve Replacement in Low‐Risk Patients: Puzzle Solved?
- 7 November 2023
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (21) , e030953
Open AccessTranscatheter Versus Surgical Aortic Valve Replacement in Low‐Risk Patients: Puzzle Solved?
- Open Access
- 7 June 2022
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 11 (11) , e025295
Circulating S‐Glutathionylated cMyBP‐C as a Biomarker for Cardiac Diastolic Dysfunction
Background: cMyBP‐C (Cardiac myosin binding protein‐C) regulates cardiac contraction and relaxation. Previously, we demonstrated that elevated myocardial S‐glutathionylation of cMyBP‐C correlates with diastolic dysfunction (DD) in animal models. In this study, we tested whether circulating S‐glutathionylated cMyBP‐C would be a biomarker for DD. Methods and Results: Humans, African Green monkeys, and mice had DD determined by echocardiography. Blood samples were acquired and analyzed for S‐glutathionylated cMyBP‐C by immunoprecipitation. Circulating S‐glutathionylated cMyBP‐C in human participants with DD (n=24) was elevated (1.46±0.13‐fold, P =0.014) when compared with the non‐DD controls (n=13). Similarly, circulating S‐glutathionylated cMyBP‐C was upregulated by 2.13±0.47‐fold ( P =0.047) in DD monkeys (n=6), and by 1.49 (1.22–2.06)‐fold ( P =0.031) in DD mice (n=5) compared with the respective non‐DD controls. Circulating S‐glutathionylated cMyBP‐C was positively correlated with DD in humans. Conclusions: Circulating S‐glutathionylated cMyBP‐C was elevated in humans, monkeys, and mice with DD. S‐glutathionylated cMyBP‐C may represent a novel biomarker for the presence of DD.
- 7 June 2022
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 11 (11) , e025295
Open AccessCirculating S‐Glutathionylated cMyBP‐C as a Biomarker for Cardiac Diastolic Dysfunction
Background: cMyBP‐C (Cardiac myosin binding protein‐C) regulates cardiac contraction and relaxation. Previously, we demonstrated that elevated myocardial S‐glutathionylation of cMyBP‐C correlates with diastolic dysfunction (DD) in animal models. In this study, we tested whether circulating S‐glutathionylated cMyBP‐C would be a biomarker for DD. Methods and Results: Humans, African Green monkeys, and mice had DD determined by echocardiography. Blood samples were acquired and analyzed for S‐glutathionylated cMyBP‐C by immunoprecipitation. Circulating S‐glutathionylated cMyBP‐C in human participants with DD (n=24) was elevated (1.46±0.13‐fold, P =0.014) when compared with the non‐DD controls (n=13). Similarly, circulating S‐glutathionylated cMyBP‐C was upregulated by 2.13±0.47‐fold ( P =0.047) in DD monkeys (n=6), and by 1.49 (1.22–2.06)‐fold ( P =0.031) in DD mice (n=5) compared with the respective non‐DD controls. Circulating S‐glutathionylated cMyBP‐C was positively correlated with DD in humans. Conclusions: Circulating S‐glutathionylated cMyBP‐C was elevated in humans, monkeys, and mice with DD. S‐glutathionylated cMyBP‐C may represent a novel biomarker for the presence of DD.
- 25 August 2021
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 7 (9) , 1079-1083
Cardiac Resynchronization and Circulating Markers of Sarcoplasmic Reticulum Calcium Handling and Sudden Death Risk
- 25 August 2021
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 7 (9) , 1079-1083
Cardiac Resynchronization and Circulating Markers of Sarcoplasmic Reticulum Calcium Handling and Sudden Death Risk
- 1 March 2021
- Published by Elsevier in Heart & Lung
- Vol. 50 (2) , 223-229
Cardiac rehabilitation in women; comparison of enrollment, adherence and outcomes between heart failure and coronary artery disease
- 1 March 2021
- Published by Elsevier in Heart & Lung
- Vol. 50 (2) , 223-229
Cardiac rehabilitation in women; comparison of enrollment, adherence and outcomes between heart failure and coronary artery disease